Drugs could still be costly under World Trade Organization deal

BMJ 2003; 327 doi: (Published 18 September 2003) Cite this as: BMJ 2003;327:639
  1. Fiona Fleck
  1. Geneva

    A landmark deal that allows poor countries without any manufacturing capability of their own to waive international trade rules and import cheap copies of patented drugs is likey to be a complex procedure that may not reduce prices enough, experts say.

    Embedded Image

    Protesters demanding a better deal for developing countries run on the beach in Cancun, Mexico, with “We are winning” on their bodies


    UN secretary general Kofi Annan issued a statement to the World Trade Organization meeting in Cancun, Mexico, last week, after the deal was clinched in Geneva, saying that it was a “moral imperative” for each of the organisation's 146 member countries to implement …

    View Full Text

    Sign in

    Log in through your institution